Benign neoplasm of stomach

Summary

Benign neoplasm of stomach (MONDO:0021449) is a cancer and 3 clinical trials. Top therapeutic interventions include cellulose, oxidized. A subtype of benign digestive system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	benign neoplasm of stomach
Mondo ID	MONDO:0021449
ICD-10-CM	D13.1
ICD-11	479576735
NCIT	C3599
SNOMED CT	92411005
UMLS	C0153943
MedGen	57805
Anatomy (UBERON)	UBERON:0000945
Is cancer (heuristic)	yes

Also known as: benign gastric neoplasm · benign gastric tumor · benign gastric tumors · benign gastric tumour · benign gastric tumours · benign neoplasm of the stomach · benign stomach neoplasms · benign stomach tumors · benign stomach tumours · benign tumor of stomach · benign tumor of the stomach · benign tumors of stomach · benign tumors of the stomach · benign tumour of stomach · benign tumour of the stomach · benign tumours of stomach · benign tumours of the stomach · gastric neoplasms, benign · gastric tumors, benign · stomach benign neoplasm (+2 more)

Disease family

This is a subtype of benign digestive system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › benign digestive system neoplasm › benign neoplasm of stomach

Related subtypes (9): intestinal benign neoplasm, bile duct papillary neoplasm, pleomorphic adenoma, hepatocellular adenoma, benign neoplasm of esophagus, benign neoplasm of pancreas, benign neoplasm of oropharynx, benign neoplasm of gallbladder, hepatobiliary benign neoplasm

Subtypes (3): gastric leiomyoma, gastric hemangioma, lipoma of stomach

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07551440	Not specified	RECRUITING	Identification of Therapeutic Targets in Metastatic Gastric Cancer
NCT01758965	Not specified	COMPLETED	Surgicel® Fibrillar for Delayed Bleeding After ESD
NCT02541461	Not specified	COMPLETED	Body Composition After Laparoscopic Gastrectomy for Gastric Cancer

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
CELLULOSE, OXIDIZED	-1	1